Moderna US, Inc

A clinical-stage drug discovery and development company applying synthetic biology to beneficial microbes to develop novel living medicines.

Amide Technologies, Inc., based in Cambridge, MA, specializes in on-demand polyamide manufacturing, offering rapid synthesis of peptides that are often difficult to obtain through traditional methods. By leveraging unnatural amino acids and artificial protein backbones, the company bridges the gap between conventional solid-phase peptide synthesis and biological expression, enabling the creation of complex compounds for drug discovery. With a minimum turnaround time of just four days and a 99% on-time delivery rate, Amide accelerates drug development by accepting urgent peptide orders that other vendors may refuse. Their innovative approach provides unprecedented access to large and unusual compounds, facilitating the search for novel therapeutic modalities and enhancing the efficiency of design-build-test cycles for their customers. Generated from the website